Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

Clinical trial NCT01445080 · COMPLETED

Trial details

NCT number: NCT01445080
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Blastic Phase Childhood Acute Promyelocytic Leukemia With PML-RARA Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Solid Neoplasm Chronic Myelogenous Leukemia, BCR-ABL1 Positive Juvenile Myelomonocytic Leukemia Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Disease

Start date: 2006-05-30
Primary completion: 2012-03-16
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.